Soft tissue sarcoma development subsequent to vaccination is often a f
atal consequence to what has been considered In the past a benign, rou
tine procedure. This article will address what is currently known abou
t the problem and make suggestions regarding the management of postvac
cinal sarcomas as well as their prevention. Although fibrosarcomas are
the most frequently associated with vaccination, malignant fibrous hi
stiocytomas, rhabdomyosarcomas, soft tissue osteosarcomas, and chondro
sarcomas have also been reported. The material contained within the ma
crophages of some of these reactions has been determined to be aluminu
m, a component of adjuvants frequently used in inactivated vaccines. B
ecause the sarcomas are difficult if not impossible to cure surgically
, attempts to determine the specific vaccines that induce them and alt
erations in routine vaccination regimens should be implemented to incr
ease the chances of surgical cure of this disease and reduce their occ
urrence.